Goldman Sachs upgrades BioNTech to buy, sees stock surging more than 25%
- Posted on November 8, 2024
- By CNBC
- 1 Views
Goldman Sachs upgrades BioNTech to buy, sees stock surging more than 25%
The bank upgraded shares of the German biotechnology firm to a buy rating from neutral.
